Integrative Physiology |
From the Cardiopulmonary Division, Department of Internal Medicine (T.K., M.S., S.M., T.S., D.H., K.F., S.O.), Keio University, Tokyo, Japan, and Department of Physiology (H.I., H.K.-N.), Tokai University, Kanagawa, Japan.
Correspondence to Keiichi Fukuda, MD, PhD, Cardiopulmonary Division, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail kfukuda{at}mc.med.keio.ac.jp
AbstractWe
recently reported that leukemia inhibitory factor (LIF) enhances
Ca2+]i through an
increase in L-type Ca2+ current
(ICa,L) in adult
cardiomyocytes. The aim of this study was to investigate whether LIF
activates Ca2+-dependent signaling
molecules, such as calcineurin and calmodulin kinases II and IV (CaMKII
and CaMKIV), and, if so, whether these
Ca2+-mediated signaling events contribute to
LIF-mediated cardiac hypertrophy. We first confirmed that LIF increased
ICa,L and
[Ca2+]i in primary
cultured rat neonatal cardiomyocytes. Calcineurin, CaMKII, and CaMKIV
activities increased at 2 minutes and peaked by 1.6-, 2.2-, and
2.2-fold, respectively, at 15 minutes. Nicardipine or verapamil fully
inhibited these activities. Autophosphorylation of CaMKII was also
observed to parallel the timing of CaMKII activity, and this
phosphorylation was blocked by nicardipine, verapamil, or EGTA. LIF
treatment led to a 3-fold increase in nuclear factor of activated T
cellluciferase activity. To confirm that inositol triphosphate
(IP3)-induced Ca2+
release from sarcoplasmic reticulum was not involved in this process,
IP3 content and phosphorylation of phospholipase
C
were investigated. LIF did not increase IP3
content or phosphorylate phospholipase C
. KN62 (an inhibitor of
CaMKII and CaMKIV) attenuated c-fos, brain natriuretic peptide,
-skeletal actin, and atrial natriuretic peptide expression. KN62
suppressed the LIF-induced increase in
[3H]phenylalanine uptake and cell size.
Cyclosporin A and FK506 slightly attenuated brain natriuretic peptide
but did not affect c-fos or atrial natriuretic peptide expression.
Cyclosporin A significantly reduced the LIF-induced increase in
[3H]phenylalanine uptake. These findings
indicated that LIF activated CaMKII, CaMKIV, and calcineurin through an
increase in ICa,L and
[Ca2+]i and that
CaMKII, CaMKIV, and calcineurin are critically involved in LIF-induced
cardiac hypertrophy.
Key Words: leukemia inhibitory factor calcium calmodulin-dependent kinase calcineurin cardiac hypertrophy
This article has been cited by other articles:
![]() |
J. Backs and E. N. Olson Control of Cardiac Growth by Histone Acetylation/Deacetylation Circ. Res., January 6, 2006; 98(1): 15 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Rueckschloss and G. Isenberg Contraction augments L-type Ca2+ currents in adherent guinea-pig cardiomyocytes J. Physiol., October 15, 2004; 560(2): 403 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chang, T. A. McKinsey, C. L. Zhang, J. A. Richardson, J. A. Hill, and E. N. Olson Histone Deacetylases 5 and 9 Govern Responsiveness of the Heart to a Subset of Stress Signals and Play Redundant Roles in Heart Development Mol. Cell. Biol., October 1, 2004; 24(19): 8467 - 8476. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fiedler and K. C Wollert Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes Cardiovasc Res, August 15, 2004; 63(3): 450 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Zhang and J. H. Brown Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure Cardiovasc Res, August 15, 2004; 63(3): 476 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vlasblom, A. Muller, R. J.P Musters, M. J Zuidwijk, C. van Hardeveld, W. J Paulus, and W. S Simonides Contractile arrest reveals calcium-dependent stimulation of SERCA2a mRNA expression in cultured ventricular cardiomyocytes Cardiovasc Res, August 15, 2004; 63(3): 537 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N Petrashevskaya, I. Bodi, S. E Koch, S. A Akhter, and A. Schwartz Effects of {alpha}1-adrenergic stimulation on normal and hypertrophied mouse hearts. Relation to caveolin-3 expression Cardiovasc Res, August 15, 2004; 63(3): 561 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Takahashi, K. Fukuda, S. Miyoshi, M. Murata, T. Kato, M. Ita, T. Tanabe, and S. Ogawa Leukemia Inhibitory Factor Activates Cardiac L-Type Ca2+ Channels via Phosphorylation of Serine 1829 in the Rabbit Cav1.2 Subunit Circ. Res., May 14, 2004; 94(9): 1242 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Zhang, S. Miyamoto, and J. H. Brown Cardiomyocyte Calcium and Calcium/Calmodulin-dependent Protein Kinase II: Friends or Foes? Recent Prog. Horm. Res., January 1, 2004; 59(1): 141 - 168. [Abstract] [Full Text] |
||||
![]() |
D. A. Linseman, C. M. Bartley, S. S. Le, T. A. Laessig, R. J. Bouchard, M. K. Meintzer, M. Li, and K. A. Heidenreich Inactivation of the Myocyte Enhancer Factor-2 Repressor Histone Deacetylase-5 by Endogenous Ca2//Calmodulin-dependent Kinase II Promotes Depolarization-mediated Cerebellar Granule Neuron Survival J. Biol. Chem., October 17, 2003; 278(42): 41472 - 41481. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Colomer, L. Mao, H. A. Rockman, and A. R. Means Pressure Overload Selectively Up-Regulates Ca2+/Calmodulin-Dependent Protein Kinase II in Vivo Mol. Endocrinol., February 1, 2003; 17(2): 183 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Sussman, A. McCulloch, and T. K. Borg Dance Band on the Titanic: Biomechanical Signaling in Cardiac Hypertrophy Circ. Res., November 15, 2002; 91(10): 888 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fiedler, S. M. Lohmann, A. Smolenski, S. Linnemuller, B. Pieske, F. Schroder, J. D. Molkentin, H. Drexler, and K. C. Wollert Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes PNAS, August 20, 2002; 99(17): 11363 - 11368. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. F Bueno, E. van Rooij, J. D Molkentin, P. A Doevendans, and L. J De Windt Calcineurin and hypertrophic heart disease: novel insights and remaining questions Cardiovasc Res, March 1, 2002; 53(4): 806 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tahara, K. Fukuda, H. Kodama, T. Kato, S. Miyoshi, and S. Ogawa Potassium channel blocker activates extracellular signal-regulated kinases through Pyk2 and epidermal growth factor receptor in rat cardiomyocytes J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1554 - 1563. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |